Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to assess Eziclen/Izinova drug utilisation in the real life setting in a representative sample of the European target population.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02630680
Study type Observational
Source Ipsen
Contact
Status Completed
Phase
Start date October 2015
Completion date April 25, 2017

See also
  Status Clinical Trial Phase
Completed NCT05032794 - Unrestricted Diet for Screening Colonoscopy N/A
Completed NCT02239692 - A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy Phase 3
Unknown status NCT01481714 - Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies Phase 4
Completed NCT02321462 - Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy Phase 3
Recruiting NCT04054388 - LINE Re-education Before Colonoscopy to Confirm Optimal Bowel Cleansing N/A
Completed NCT01864915 - Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule Phase 3
Completed NCT03631446 - Drug Use-Results Survey on Picoprep® Combination Powder
Recruiting NCT05354609 - DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease N/A
Completed NCT04852120 - Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population